The influenza vaccines market was valued at US$ 7,478.53 million in 2021 and it is expected to grow US$ 12,272.49 million by 2028; with a CAGR of 7.4% from 2022 to 2028
Influenza is a contagious respiratory infection caused due to influenza virus. Influenza is noticed by fever, cough, muscle and joint pain, headache, and severe weakness. Illness due to influenza varies from mild to severe, sometimes leading to death. According to the World Health Organization (WHO), 2018, influenza cases related hospitalization ranges from 3-5 million cases for severe illness, whereas deaths related to influenza are about 290,000 to 650,000. Vaccines are adviced for the prevention of influenza infections. The rapid spread of influenza virus epidemics worldwide propels demands for developing an efficient influenza vaccine. A strong product pipeline is a key factor driving the market's growth during the forecast period.
The influenza vaccines market is analyzed on the basis of vaccine type, virus type, technology, route of administration, target group, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The influenza vaccines market report offers insights and in-depth analysis of the market, emphasizing market trends, technological advancements, market dynamics, and the competitive analysis of the leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Influenza Vaccines Market: Strategic Insights
Market Size Value in US$ 7,478.53 Million in 2021 Market Size Value by US$ 12,272.49 Million by 2028 Growth rate CAGR of 7.4% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Influenza Vaccines Market: Strategic Insights
| Market Size Value in | US$ 7,478.53 Million in 2021 |
| Market Size Value by | US$ 12,272.49 Million by 2028 |
| Growth rate | CAGR of 7.4% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Lucrative Regions for Influenza Vaccines Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Investment by Top Market Players and Governments to Drive Influenza Vaccines Market
Market players and governments worldwide are increasing their investments in vaccine development and immunization. For instance, In March 2021, Sanofi announced an approximately US$ 925 million investments in a new vaccine manufacturing plant at its pre-existing site in Toronto and Canada. Investments in the new facility will provide additional antigen and filling capacity for Sanofi's FLUZONE high-dose quadrivalent influenza vaccines, increasing availability in Canada, the US, and Europe in the years to come.
- In April 2021, 3 levels of government - federal, provincial and municipal - supported Sanofi Pasteur in building an "end-to-end" influenza vaccines factory in Toronto. The partners will invest nearly US$ 1 billion to get the site up and running, slated for 2027. Paris-based Sanofi, for its part, will invest more than US$ 55 million, create 165 new eligible jobs, and maintain another 1,100. The federal government is investing US$ 55 million, while the Ontario government is contributing US$ 55 million, making it a US$ 925 million project. In addition, Sanofi will also invest at least US$ 79 million annually over 8 years to fund research and development in Canada.
- In November 2020, Vaccine maker Seqirus planned to invest US$ 800 million in a significant Australian vaccine manufacturing center. The new plant will be located at Tullamarine in the business district of Melbourne Airport and is expected to come online in 2026, Seqirus said. The company did not disclose the desired square meter area in a statement.
- In March 2022, The Australian Government announced a US$ 100 million investments in a seasonal flu vaccine. The objective of this investment is to protect people from influenza and COVID-19 to minimize its impact on healthcare in Australia.
- In June 2021, The European Investment Bank signed a US$ 30.55 million global vaccine distribution agreement with biotech company Univercells to mass produce the COVID-19 vaccine at a new Belgian site. It helped build other vaccine factories around the world. In April 2022, the Bank provided a US$ 15.27 million loan to Italian biomedical research company IRBM to expand its vaccine production capacity and strengthen research on coronaviruses and other diseases.
Thus, the increase in investment by top market players and governments across the globe is bolstering the influenza vaccines market.
Vaccine Type Insights
Based on vaccine type, the global influenza vaccines market is segmented into quadrivalent vaccines and trivalent vaccines. The quadrivalent segment held a larger share of the market in 2021. The same segment is expected to grow faster over the forecast period. The increasing product approvals and rising product launches for market expansion are among the primary drivers of the quadrivalent vaccine segment growth.
Influenza Vaccines Market, by Vaccine Type – during 2022–2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Virus Type Insights
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on virus type, the global influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger market share in 2021. The same is expected to grow faster over the forecast period due to the increasing prevalence of influenza type A. The market growth of the influenza virus type A segment is attributed to it being the most common form of influenza. It can infect animals, although illnesses associated with this type of flu are more common.
Product Approvals and Collaborations are highly adopted strategies by influenza vaccines market players. A few of the recent key market developments are listed below:
- In July 2022, The US Food and Drug Administration (FDA) approved Sanofi's licensure request for vaccine approval for the upcoming 2022-2023 flu season, including Fluzone High-Dose Quadrivalent (Influenza Vaccine), Flublok Quadrivalent (Influenza Vaccine), and Fluzone Quadrivalent (Influenza Vaccine). This approval comes on the heels of the CDC's Advisory Committee on Immunization Practices (ACIP) preferential recommendation for adults 65+ including Fluzone High-Dose Quadrivalent and Flublok Quadrivalent.
- In July 2022, GSK announced an agreement with the Government of Canada for pandemic and seasonal influenza vaccines to help protect Canadian adults and children. The four-year agreement, spanning through March 2026, includes the supply of as many as 80 million doses of Arepanrix (adjuvanted pandemic influenza vaccine) in the event of an influenza pandemic(s) and a minimum of 4 million doses per year of Flulaval Tetra (seasonal influenza vaccine).
The COVID-19 pandemic is expected to boost the global influenza vaccines market growth, owing to the increasing demand for influenza vaccines during a pandemic. According to data published by the Centers for Disease Control and Prevention in November 2021, the overall influenza vaccine administration in the US increased by 9.0% from September to December 2020, with more doses administered to adolescents and adults than in September to December 2018 and 2019.
Influenza Vaccines– Market Segmentation
The global influenza vaccines market is analyzed on the basis of vaccine type, virus type, technology, route of administration, target group, and geography. Based on vaccine type, the market is segmented into quadrivalent vaccines and trivalent vaccines. Based on virus type, the market is segmented into influenza virus type A and influenza virus type B. Based on technology, the market is bifurcated into egg-based and cell-based. Based on route of administration, the market is segmented into injection and nasal spray. Based on target group, the market can be segmented into infants, children, adults, and elderly. By geography, the influenza vaccines market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.
Company Profiles
Moderna, Inc.; SEQIRUS; Sanofi; GlaxoSmithKline plc; Hualan Biological Engineering Inc.; Emergent BioSolutions Inc.; Mitsubishi Chemical Group Corporation; Serum Institute of India Pvt. Ltd; Mylan N. V.; and AstraZeneca are the key companies operating in the influenza vaccines market. The companies are taking up product innovation strategies to meet the evolving customer demands globally, allowing them to maintain their brand name in the global influenza vaccines market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSAM, Saudi Arabia, South Africa, South Korea, Spain, Switzerland, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The quadrivalent segment held the larger share of the market in the global influenza vaccines market contributing a market share of 88.36% in 2022.
The Asia Pacific is expected to be the fastest-growing region in the influenza vaccines market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and influenza cases in these regions will show promising growth in the influenza vaccines market.
The influenza vaccines market is estimated to be valued at US$ 7,478.53 million in 2021.
The influenza vaccines market is expected to be valued at US$ 12,272.49 million in 2028.
The CAGR value of the influenza vaccines market during the forecasted period of 2022-2028 is 7.4%.
The influenza vaccines market majorly consists of the players, such as Moderna, Inc.; SEQIRUS; Sanofi; GlasoSmithKline plc; Hualan Biological Engineering Inc.; Emergent Biosolutions Inc.; Mitsubishi Chemical Group Corporation; Serum Institute of India Pvt. Ltd; Mylan N. V.; and AstraZeneca
The factors that are driving the growth of the influenza vaccines market are increase in government support to promote influenza vaccination and increasing investment by top market players and governments.
Influenza virus causes flu which is a contagious respiratory illness that infects nose, throat and lungs. It can mild or severe and sometimes may lead to death. Flu vaccination every year can help in preventing flu. However, this can be deadly, especially in high-risk groups. Aged population, pregnant women and people with one or more chronic disease or with weak immune systems are at high risk. Influenza vaccines/flu shots protect against the four influenza viruses’ subtypes that are most common. Most of the influenza vaccines are “flu shots†given with a needle, usually in the arm, but nasal spray flu vaccine are also available.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Influenza Vaccines Market – By Vaccine Type
1.3.2 Global Influenza Vaccines Market – By Virus Type
1.3.3 Global Influenza Vaccines Market – By Technology
1.3.4 Global Influenza Vaccines Market – By Route of Administration
1.3.5 Global Influenza Vaccines Market – By Target Group
1.3.6 Global Influenza Vaccines Market – By Geography
2. Influenza Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Influenza Vaccines Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Global Influenza Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market –Global Analysis
6.1 Global Influenza Vaccines Market Revenue Forecasts And Analysis
6.2 Global Influenza Vaccines Market, By Geography - Forecasts And Analysis
6.3 Global Influenza Vaccines Market – Market Potential Analysis, By Region
6.4 Company Analysis
6.4.1 Market Positioning of Key Players
6.4.2 Comparative Company Analysis
6.5 Growth Strategy Analysis
6.6 Performance of Key Players
6.6.1 Sanofi
6.6.2 SEQIRUS
7. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Vaccine Type
7.1 Overview
7.2 Global Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Virus Type
8.1 Overview
8.2 Global Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 Influenza Virus Type A Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 Influenza Virus Type B Market Revenue and Forecast to 2028 (US$ Mn)
9. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Technology
9.1 Overview
9.2 Global Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.3 Egg-based
9.3.1 Overview
9.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
9.4.1 Overview
9.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Route of Administration
10.1 Overview
10.2 Global Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.3 Injection
10.3.1 Overview
10.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Target Group
11.1 Overview
11.2 Global Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
11.3 Infants
11.3.1 Overview
11.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
11.4.1 Overview
11.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
11.5.1 Overview
11.5.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
11.6.1 Overview
11.6.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
12. Influenza Vaccines Market Analysis and Forecasts To 2028 – Geographical Analysis
12.1 North America Influenza Vaccines Market Revenue and Forecasts To 2028
12.1.1 Overview
12.1.2 North America: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3 North America: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.4 North America: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.5 North America: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.6 North America: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.7 North America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.8 North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.1.8.1 US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.1 Overview
12.1.8.1.2 US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.3 US: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.8.1.4 US: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.8.1.5 US: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.8.1.6 US: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.8.1.7 US: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.8.2 Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.1 Overview
12.1.8.2.2 Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.3 Canada: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.8.2.4 Canada: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.8.2.5 Canada: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.8.2.6 Canada: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.8.2.7 Canada: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.8.3 Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.1 Overview
12.1.8.3.2 Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.3 Mexico: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.8.3.4 Mexico: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.8.3.5 Mexico: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.8.3.6 Mexico: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.8.3.7 Mexico: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2 Europe: Influenza Vaccines Market
12.2.1 Overview
12.2.2 Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.3 Europe: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.4 Europe: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.5 Europe: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.6 Europe: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.7 Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8 Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.2.8.1 Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.1 Overview
12.2.8.1.2 Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.3 Germany: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.1.4 Germany: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.1.5 Germany: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.1.6 Germany: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.1.7 Germany: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.2 UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.1 Overview
12.2.8.2.2 UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.3 UK: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.2.4 UK: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.2.5 UK: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.2.6 UK: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.2.7 UK: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.3 France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.1 Overview
12.2.8.3.2 France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.3 France: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.3.4 France: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.3.5 France: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.3.6 France: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.3.7 France: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.4 Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.1 Overview
12.2.8.4.2 Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.3 Italy: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.4.4 Italy: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.4.5 Italy: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.4.6 Italy: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.4.7 Italy: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.5 Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.1 Overview
12.2.8.5.2 Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.3 Spain: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.5.4 Spain: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.5.5 Spain: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.5.6 Spain: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.5.7 Spain: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.6 Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.3 Rest of Europe: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.6.4 Rest of Europe: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.6.5 Rest of Europe: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.6.6 Rest of Europe: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.6.7 Rest of Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3 Asia Pacific: Influenza Vaccines Market
12.3.1 Overview
12.3.2 Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.3 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.4 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.5 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.6 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.7 Asia Pacific: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8 Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.3.8.1 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.1.1 Overview
12.3.8.1.2 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.1.3 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.1.4 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.1.5 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.1.6 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.1.7 Japan: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.2.1 Overview
12.3.8.2.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.2.3 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.2.4 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.2.5 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.2.6 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.2.7 China: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.3 India Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.3.1 Overview
12.3.8.3.2 India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.3.3 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.3.4 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.3.5 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.3.6 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.3.7 India: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.4.1 Overview
12.3.8.4.2 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.4.3 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.4.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.4.5 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.4.6 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.4.7 South Korea: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.5.1 Overview
12.3.8.5.2 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.5.3 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.5.4 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.5.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.5.6 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.5.7 Australia: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.6 Rest of Asia Pacific: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.3 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.6.4 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.6.5 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.6.6 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.6.7 Rest of Asia Pacific: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4 Middle East & Africa Influenza Vaccine Market Revenue and Forecasts To 2028
12.4.1 Overview
12.4.2 Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.4.3 Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.4 Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.5 Middle East & Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
12.4.6 Middle East & Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.7 Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4.8 Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
12.4.8.1 Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.1 Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.8.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.8.1.4 Saudi Arabia Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.6 Saudi Arabia: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4.8.2 UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.1 UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.8.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.8.2.4 UAE Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.5 UAE Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.6 UAE: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4.8.3 South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.1 South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.8.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.8.3.4 South Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.5 South Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.6 South Africa: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4.8.4 Rest of Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.4.1 Rest of Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.4.2 Rest of Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.8.4.3 Rest of Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.8.4.4 Rest of Middle East & Africa: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.4.8.4.5 Rest of Middle East & Africa: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.4.8.4.6 Rest of Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.5 South and Central America Influenza Vaccine Market Revenue and Forecasts To 2028
12.5.1 Overview
12.5.2 South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.3 South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.5.4 South and Central America: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.5.5 South and Central America: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.5.6 South and Central America: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.5.7 South and Central America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.5.8 South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
12.5.8.1 Brazil: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.1.1 Overview
12.5.8.1.2 Brazil: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.1.3 Brazil: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.5.8.1.4 Brazil: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.5.8.1.5 Brazil: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.5.8.1.6 Brazil: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.5.8.1.7 Brazil: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.5.8.2 Argentina: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.2.1 Overview
12.5.8.2.2 Argentina: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.2.3 Argentina: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.5.8.2.4 Argentina: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.5.8.2.5 Argentina: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.5.8.2.6 Argentina: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.5.8.2.7 Argentina: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.5.8.3 Rest of South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.3.1 Overview
12.5.8.3.2 Rest of South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.3.3 Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.5.8.3.4 Rest of South and Central America: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.5.8.3.5 Rest of South and Central America: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.5.8.3.6 Rest of South and Central America: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.5.8.3.7 Rest of South and Central America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
13. Impact of COVID-19 Pandemic on Global Influenza Vaccines Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13.5 South and Central America: Impact Assessment of COVID-19 Pandemic
14. Influenza Vaccine Market –Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
14.3 Inorganic Growth Strategies
14.3.1 Overview
14.4 Organic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 Moderna, Inc.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 SEQIRUS
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Sanofi
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 GlaxoSmithKline plc.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Hualan Biological Engineering Inc.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Emergent BioSolutions Inc.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Mitsubishi Chemical Group Corporation
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Serum Institute of India Pvt. Ltd
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 MYLAN N.V.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 AstraZeneca
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 5. North America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 6. US Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 21. Europe Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 26. Germany Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 31. UK Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 36. France Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 37. France: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. France Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 39. France Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 40. France Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 41. Italy Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 46. Spain Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Europe Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Europe Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Europe Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 56. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million).
Table 57. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 58. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 59. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Segment-5 (US$ Million)
Table 60. Asia Pacific Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 61. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 62. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 63. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 64. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 65. Japan Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 66. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 67. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 68. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 69. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 70. China Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 71. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 72. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 73. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 74. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 75. India Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 76. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 77. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 78. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 79. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 80. South Korea Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 81. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 82. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 83. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 84. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 85. Australia Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 87. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 88. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 89. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 90. Rest of Asia Pacific Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East & Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East & Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East & Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East & Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East & Africa Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 96. Saudi Arabia Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Influenza Vaccine Market, by Virus Type– Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 101. UAE Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East & Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East & Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East & Africa Influenza Vaccine Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East & Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East & Africa Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 136. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
Table 137. Recent Organic Growth Strategies in the Influenza Vaccine Market
Table 138. Glossary of Terms, Influenza Vaccines Market
LIST OF FIGURES
Figure 1. Influenza Vaccines Market Segmentation
Figure 2. Influenza Vaccines Market Segmentation, by Region
Figure 3. Global Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Influenza Vaccines Market
Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Influenza Vaccines Market, By Geography (USD Million)
Figure 7. Global Influenza Vaccines Market- Leading Country Markets (USD Million)
Figure 8. Global Influenza Vaccines Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 16. Global Influenza Vaccines Market – By Geography Forecasts and Analysis – 2022- 2028
Figure 17. Global Influenza Vaccines Market – Market Potential Analysis, By Region
Figure 18. Market Positioning of Key Players In Global Influenza Vaccines Market
Figure 19. Global Influenza Vaccines Market – Comparative Company Analysis
Figure 20. Global Influenza Vaccines Market – Growth Strategy Analysis
Figure 21. Global Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 22. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Global Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 25. Powder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Tablets Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Global Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 28. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Global Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 31. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. Global Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
Figure 34. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. North America: Influenza Vaccines Market, by Key Country – Revenue (2022) (US$ Million)
Figure 39. North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 41. US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Influenza Vaccines Market, by Key Country – Revenue (2022) (US$ Million)
Figure 45. Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 47. Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Asia Pacific Influenza Vaccines Market Overview, by Country (2022)
Figure 54. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 56. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 58. India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 60. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. Rest of Asia Pacific: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Middle East & Africa: Influenza Vaccine Market, by Key Country – Revenue (2022) (US$ Million)
Figure 63. Middle East & Africa Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
Figure 64. Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 65. Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. Rest of Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. South and Central America: Influenza Vaccine Market, by Key Country – Revenue (2022) (USD Million)
Figure 70. South and Central America Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
Figure 71. South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 72. Brazil: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. Argentina: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. Rest of South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Impact of COVID-19 Pandemic on North America Countries
Figure 76. Impact of COVID-19 Pandemic on European Countries
Figure 77. Impact of COVID-19 Pandemic on Asia Pacific Countries
Figure 78. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 79. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 80. Growth Strategies in the Influenza Vaccine Market, 2021-2028
. 172
The List of Companies - Influenza Vaccines Market
- Moderna, Inc.
- SEQIRUS
- Sanofi
- GlaxoSmithKline plc.
- Hualan Biological Engineering Inc.
- Emergent BioSolutions Inc.
- Mitsubishi Chemical Group Corporation
- Serum Institute of India Pvt. Ltd
- MYLAN N.V.
- AstraZeneca
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Influenza Vaccines Market
Oct 2022
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Oct 2022
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Oct 2022
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Oct 2022
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Oct 2022
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2022
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2022
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
Oct 2022
Infectious Disease Therapeutics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Anti-viral, Anti Bacterial, Anti-Fungal, and Others), Indication (HIV, Hepatitis, Tuberculosis, Influenza, HPV, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Get Free Sample For